Preview Mode Links will not work in preview mode

Medscape InDiscussion: Schizophrenia

Aug 2, 2022

Drs John Kane and Stefan Leucht discuss the effectiveness and optimal dosing of antipsychotic medications in the treatment of schizophrenia.

Relevant disclosures can be found with the episode show notes on Medscape ( The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.


Toward a Phenomenological Psychotherapy for Schizophrenia

APA Releases New Practice Guideline on Treatment of Patients with Schizophrenia

Pharmacological Treatments for First-Episode Schizophrenia

Putting the Efficacy of Psychiatric and General Medicine Medication Into Perspective: Review of Meta-analyses

The Nature of Relapse in Schizophrenia

20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia

Amisulpride and Olanzapine Followed by Open-Label Treatment With Clozapine in First-Episode Schizophrenia and Schizophreniform Disorder (OPTiMiSE): A Three-Phase Switching Study


Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study

Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia

Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis

Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia